Demographic and Clinical Characteristics of the Study Participants
| Total(N = 268,792) | Hypertension(N = 217,953) | Diabetes Mellitus(N = 160,082) | Hypertension and Diabetes Mellitus(N = 109,225) | |
|---|---|---|---|---|
| Age (50 to 74 years) (mean ± SD) | 63.7 ± 6.3 | 64.1 ± 6.1 | 63.5 ± 6.3 | 64.3 ± 6.1 |
| Sex (% women) | 49.4 | 49.7 | 48.0 | 48.0 |
| Low SES (%) | 41.2 | 40.0 | 45.8 | 45.6 |
| BMI (mean ± SD) | 30.0 ± 5.5 | 30.2 ± 5.6 | 30.4 ± 5.6 | 30.9 ± 5.7 |
| Charlson score (mean ± SD) | 1.9 ± 1.7 | 1.9 ± 1.8 | 2.5 ± 1.8 | 2.7 ± 1.9 |
| MI (%) | 12.2 | 13.3 | 13.6 | 16.3 |
| s/p CVA (%) | 8.8 | 10.0 | 9.7 | 12.4 |
| Hemoglobin (mean ± SD) | 13.6 ± 1.4 | 13.5 ± 1.4 | 13.4 ± 1.4 | 13.3 ± 1.5 |
| Creatinine (mean ± SD) | 0.9 ± 0.5 | 0.9 ± 0.6 | 0.9 ± 0.6 | 0.9 ± 0.7 |
| LDL (mean ± SD) | 92.7 ± 30.3 | 93.0 ± 30.5 | 87.4 ± 29.5 | 85.8 ± 29.3 |
| HbA1c (mean ± SD) | 7.3 ± 1.4 | 7.3 ± 1.4 | ||
| Number of medications* (mean ± SD) | 2.1± | 2.2 ± 1.1 | 2.3 ± 1.2 | 2.6 ± 1.2 |
| Number of family physician visits in 2017 (mean ± SD) | 13.1 ± 8.7 | 13.3 ± 8.7 | 13.8 ± 9.1 | 14.6 ± 9.5 |
BMI, body mass index; CVA, cerebrovascular event; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; MI, myocardial infarction; SD, standard deviation; SES, socioeconomic status.
↵* Total medications of the medications examined.